BlackRock Health Sciences Term Trust
 
 
 
 
基本資料
種類: ETF
費用比率%: 1.37
資產淨值: 18.71
成立日期: 29/01/2020
 
分析
市值分佈:
73.81%
大市值
6.32%
中市值
2.18%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 19/09/2026 05:40) 總持有投資項目: 79  
0%
 
100%
     10大 (25.53%)
代號 名稱 佔比% ▼ 持有日期
BBIOBridgeBio Pharma1.0531/03/2026
DHRDanaher Corp1.0531/03/2026
MDTMedtronic plc1.0331/03/2026
VRTXVertex Pharmaceuticals0.9730/06/2026
ESALFEisai Co., Ltd.0.9631/03/2026
TECHBio-Techne Corp0.9131/03/2026
MBXMBX Biosciences Inc.0.6630/06/2026
ABTAbbott Laboratories0.5830/06/2026
GSKGSK plc0.5530/06/2026
LNTHLantheus Holdings0.5030/06/2026
WXIBFWuxi Biologics (Cayman) Inc0.4730/06/2026
LBRXLB Pharmaceuticals Inc0.4431/12/2025
INCYIncyte Corp0.4330/06/2026
RCUSArcus Biosciences0.3731/03/2026
AGIOAgios Pharmaceuticals0.3531/03/2026
KNSAKiniksa Pharmaceuticals International, plc0.3231/03/2026
PODDInsulet Corp0.3030/06/2026
EWTXEdgewise Therapeutics0.2931/03/2026
RDNTRadNet0.2731/03/2026
ELVNEnliven Therapeutics0.2630/06/2026
  1   2    3    4  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.